Biomedical Engineering Reference
In-Depth Information
176. Higuchi, Y.,
et al.
, h e potential role of fucosylated cationic liposome/
NFkappaB decoy complexes in the treatment of cytokine-related liver dis-
ease.
Biomaterials
, 2007. 28(3): p. 532-9.
177. Yamada, Y.,
et al.
, Postinfarct active cardiac-targeted delivery of erythropoi-
etin by liposomes with sialyl Lewis X repairs infarcted myocardium in rab-
bits.
Am J Physiol Heart Circ Physiol
, 2013. 304(8): p. H1124-33.
178. Hirai, M.,
et al.
, Accumulation of liposome with Sialyl Lewis X to inl amma-
tion and tumor region: application to in vivo bio-imaging.
Biochem Biophys
Res Commun
, 2007. 353(3): p. 553-8.
179. Chang, D.K.,
et al.
, A novel peptide enhances therapeutic ei cacy of lipo-
somal anti-cancer drugs in mice models of human lung cancer.
PLoS One
,
2009. 4(1): p. e4171.
180. Allon, N.,
et al.
, A new liposome-based gene delivery system targeting lung epi-
thelial cells using endothelin antagonist.
J Control Release
, 2012. 160(2): p. 217-24.
181. Tagalakis, A.D.,
et al.
, Receptor-targeted liposome-peptide nanocomplexes
for siRNA delivery.
Biomaterials
, 2011. 32(26): p. 6302-15.
182. Bedi, D.,
et al.
, Delivery of siRNA into breast cancer cells via phage fusion
protein-targeted liposomes.
Nanomedicine
, 2011. 7(3): p. 315-23.
183. Jayanna, P.K., V.P. Torchilin, and V.A. Petrenko, Liposomes targeted by
fusion phage proteins.
Nanomedicine
, 2009. 5(1): p. 83-9.
184. Shahin, M.,
et al.
, Engineered breast tumor targeting peptide ligand modi-
i ed liposomal doxorubicin and the ef ect of peptide density on anticancer
activity.
Biomaterials
, 2013. 34(16): p. 4089-97.
185. Shrof , K. and E. Kokkoli, PEGylated liposomal doxorubicin targeted to
alpha5beta1-expressing MDA-MB-231 breast cancer cells.
Langmuir
, 2012.
28(10): p. 4729-36.
186. Li, C.,
et al.
, Tumor-targeted liposomal
Drug Deliv
ery mediated by a diseleno
bond-stabilized cyclic peptide.
Int J Nanomedicine
, 2013. 8: p. 1051-62.
187. Wang, T.,
et al.
, In vitro optimization of liposomal nanocarriers prepared
from breast tumor cell specii c phage fusion protein.
J Drug Target
, 2011.
19(8): p. 597-605.
188. Koda, Y.,
et al.
, In vitro stability and permeability studies of liposomal deliv-
ery systems for a novel lipophilic endomorphin 1 analogue.
Int J Pharm
,
2008. 356(1-2): p. 37-43.
189. Shirakawa, M.,
et al.
, Synthesis and evaluation of a novel liposome contain-
ing BPA-peptide conjugate for BNCT.
Appl Radiat Isot
, 2009. 67(7-8 Suppl):
p. S88-90.
190. Hulsermann, U.,
et al.
, Uptake of apolipoprotein E fragment coupled lipo-
somes by cultured brain microvessel endothelial cells and intact brain capil-
laries.
J Drug Target
, 2009. 17(8): p. 610-8.
191. He, X.,
et al.
, A novel peptide probe for imaging and targeted delivery of lipo-
somal doxorubicin to lung tumor.
Mol Pharm
, 2011. 8(2): p. 430-8.
192. Katanasaka, Y.,
et al.
, Cancer antineovascular therapy with liposome
Drug
Deliv
ery systems targeted to BiP/GRP78.
Int J Cancer
, 2010. 127(11): p. 2685-98.
